Intrathecal Dexmedetomidine With Bupivacaine for Spinal Anesthesia in Cesarean Section
Status:
Completed
Trial end date:
2015-10-01
Target enrollment:
Participant gender:
Summary
A Randomized, Controlled, Double blind study aiming to evaluate the analgesic potentials and
side effect profile of different dose levels of Dexmedetomidine added to subarachnoid
bupivacaine in full-term pregnant women undergoing elective cesarean section using spinal
anesthesia. The investigators ultimate goal is to find out the least effective dose which
will be associated with minimal or no side effects. The primary outcome will be the time to
two sensory block segment regression.